# Preoperative Bevacizumab for Vitreous Hemorrhage

> **NCT00596297** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 16 (actual)

## Conditions studied

- Diabetic Retinopathy
- Vitreous Hemorrhage

## Interventions

- **DRUG:** bevacizumab
- **PROCEDURE:** pars plana vitrectomy

## Key facts

- **NCT ID:** NCT00596297
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2008-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596297, "Preoperative Bevacizumab for Vitreous Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00596297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*